These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14704593)

  • 1. Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone.
    Miller NS; Greenfeld A
    Am J Ther; 2004; 11(1):26-32. PubMed ID: 14704593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
    Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
    J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of opioid dependence and abuse prevalence in the United States between 2017 and 2018.
    Regueras E; Guzmán JL
    J Opioid Manag; 2022; 18(3):205-221. PubMed ID: 35666477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
    Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
    Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likeability and abuse liability of commonly prescribed opioids.
    Wightman R; Perrone J; Portelli I; Nelson L
    J Med Toxicol; 2012 Dec; 8(4):335-40. PubMed ID: 22992943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.
    Weiner SG; Hendricks MA; El Ibrahimi S; Ritter GA; Hallvik SE; Hildebran C; Weiss RD; Boyer EW; Flores DP; Nelson LS; Kreiner PW; Fischer MA
    PLoS One; 2022; 17(4):e0266561. PubMed ID: 35381052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription OxyContin abuse among patients entering addiction treatment.
    Carise D; Dugosh KL; McLellan AT; Camilleri A; Woody GE; Lynch KG
    Am J Psychiatry; 2007 Nov; 164(11):1750-6. PubMed ID: 17974941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A profile of OxyContin addiction.
    Hays LR
    J Addict Dis; 2004; 23(4):1-9. PubMed ID: 15339710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States.
    Cicero TJ; Ellis MS; Surratt HL; Kurtz SP
    Pain; 2013 Dec; 154(12):2639-2648. PubMed ID: 24287106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse.
    Brownstein JS; Green TC; Cassidy TA; Butler SF
    Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):627-37. PubMed ID: 20535759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study.
    Black JC; Margolin ZR; Olson RA; Dart RC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17073. PubMed ID: 32597786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
    Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
    Curr Med Res Opin; 2022 Nov; 38(11):1947-1957. PubMed ID: 36000252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
    Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
    Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory study of OxyContin use among individuals with substance use disorders.
    Levy MS
    J Psychoactive Drugs; 2007 Sep; 39(3):271-6. PubMed ID: 18159780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.
    Graziani M; Nisticò R
    Pharmacol Res; 2016 Jun; 108():31-38. PubMed ID: 27107788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports.
    Miller NS; Swiney T; Barkin RL
    Am J Ther; 2006; 13(5):436-44. PubMed ID: 16988540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.